MGLN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MGLN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
The historical rank and industry rank for Magellan Health's Beneish M-Score or its related term are showing as below:
During the past 13 years, the highest Beneish M-Score of Magellan Health was 1.09. The lowest was -10.21. And the median was -2.36.
The historical data trend for Magellan Health's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Magellan Health Annual Data | |||||||||||||||||||||
Trend | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | |||||||||||
Beneish M-Score | Get a 7-Day Free Trial | -2.29 | -2.33 | - | - | - |
Magellan Health Quarterly Data | ||||||||||||||||||||
Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | |
Beneish M-Score | Get a 7-Day Free Trial | - | - | - | - | - |
For the Healthcare Plans subindustry, Magellan Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Magellan Health's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Magellan Health's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Magellan Health for today is based on a combination of the following eight different indices:
M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
= | -4.84 | + | 0.92 * 1.0896 | + | 0.528 * 1.36 | + | 0.404 * 0.7626 | + | 0.892 * 1.0026 | + | 0.115 * 1.0749 | |
- | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI | |||||||
- | 0.172 * 1 | + | 4.679 * -0.010223 | - | 0.327 * 0.793 | |||||||
= | -2.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Dec20) TTM: | Last Year (Dec19) TTM: |
Total Receivables was $744 Mil. Revenue was $4,578 Mil. Gross Profit was $119 Mil. Total Current Assets was $2,156 Mil. Total Assets was $3,360 Mil. Property, Plant and Equipment(Net PPE) was $137 Mil. Depreciation, Depletion and Amortization(DDA) was $119 Mil. Selling, General, & Admin. Expense(SGA) was $0 Mil. Total Current Liabilities was $738 Mil. Long-Term Debt & Capital Lease Obligation was $632 Mil. Net Income was $382 Mil. Gross Profit was $-34 Mil. Cash Flow from Operations was $451 Mil. |
Total Receivables was $681 Mil. Revenue was $4,566 Mil. Gross Profit was $161 Mil. Total Current Assets was $1,673 Mil. Total Assets was $3,092 Mil. Property, Plant and Equipment(Net PPE) was $132 Mil. Depreciation, Depletion and Amortization(DDA) was $132 Mil. Selling, General, & Admin. Expense(SGA) was $0 Mil. Total Current Liabilities was $910 Mil. Long-Term Debt & Capital Lease Obligation was $679 Mil. |
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
= | (743.502 / 4577.531) | / | (680.569 / 4565.613) | |
= | 0.162424 | / | 0.149064 | |
= | 1.0896 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
= | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) | |
= | (161.137 / 4565.613) | / | (118.791 / 4577.531) | |
= | 0.035294 | / | 0.025951 | |
= | 1.36 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
= | (1 - (2156.397 + 136.739) / 3359.855) | / | (1 - (1673.043 + 131.712) / 3092.173) | |
= | 0.31749 | / | 0.416347 | |
= | 0.7626 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
SGI | = | Sales_t | / | Sales_t-1 |
= | Revenue_t | / | Revenue_t-1 | |
= | 4577.531 | / | 4565.613 | |
= | 1.0026 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
= | (131.509 / (131.509 + 131.712)) | / | (118.745 / (118.745 + 136.739)) | |
= | 0.499614 | / | 0.464784 | |
= | 1.0749 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
= | (0 / 4577.531) | / | (0 / 4565.613) | |
= | 0 | / | 0 | |
= | 1 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
= | ((631.855 + 737.579) / 3359.855) | / | ((679.125 + 910.147) / 3092.173) | |
= | 0.407587 | / | 0.513966 | |
= | 0.793 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
= | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t | |
= | (382.335 - -34.078 | - | 450.761) | / | 3359.855 | |
= | -0.010223 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Magellan Health has a M-score of -2.27 suggests that the company is unlikely to be a manipulator.
Thank you for viewing the detailed overview of Magellan Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Mostafa Kamal | officer: CEO, Magellan Rx Management | 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260 |
Jeffrey N West | officer: SVP & Controller | 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046 |
David Bourdon | officer: Chief Financial Officer | 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034 |
Peter A Feld | director | 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301 |
Swati Bargotra Abbott | director | 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251 |
Steven J Shulman | director | 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329 |
Guy P Sansone | director | C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323 |
Gregory Scott Mackenzie | director | NDC PLAZA ATLANTA GA 30329 |
Leslie V Norwalk | director | C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130 |
Christopher J Chen | director | 4801 EAST WASHINGTON STREET PHOENIX AZ 85034 |
Mural R Josephson | director | |
James E Murray | officer: President and COO | 500 WEST MAIN STREET, LOUISVILLE KY 40202 |
Clapper Caskie Lewis | officer: Chief Human Resources Officer | 55 NOD ROAD AVON CT 06001 |
Kenneth J Fasola | director, officer: Chief Executive Officer | 500 WEST MAIN STREET, LOUISVILLE KY 40202 |
Jonathan N Rubin | officer: Chief Financial Officer | 55 NOD ROAD AVON CT 06001 |
From GuruFocus
By Business Wire Business Wire • 12-09-2021
By Business Wire Business Wire • 12-14-2021
By Business Wire Business Wire • 07-21-2021
By Business Wire Business Wire • 05-20-2021
By Business Wire Business Wire • 11-01-2021
By Business Wire Business Wire • 12-16-2021
By Business Wire Business Wire • 10-07-2021
By Business Wire Business Wire • 09-01-2021
By Business Wire Business Wire • 11-15-2021
By GuruFocus Research GuruFocus Editor • 08-24-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.